{
  "id": "c9beb0f5cca1ffbd",
  "title": "FDA Approves Amgen UPLIZNA\u00ae ( inebilizumab - cdon ) for Generalized Myasthenia Gravis ( gMG ), Expanding Treatment Options for Patients Living with Autoimmune Neuromuscular Disease",
  "description": "20251212T183000Z",
  "content": "",
  "source": "manilatimes.net",
  "source_url": "https://www.manilatimes.net/2025/12/13/tmt-newswire/globenewswire/fda-approves-amgens-uplizna-inebilizumab-cdon-for-generalized-myasthenia-gravis-gmg-expanding-treatment-options-for-patients-living-with-autoimmune-neuromuscular-disease/2242677",
  "published_at": "20251212T183000Z",
  "fetched_at": "2025-12-13T00:21:55.936102+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda"
  ],
  "location": "Philippines",
  "raw_data": {
    "url": "https://www.manilatimes.net/2025/12/13/tmt-newswire/globenewswire/fda-approves-amgens-uplizna-inebilizumab-cdon-for-generalized-myasthenia-gravis-gmg-expanding-treatment-options-for-patients-living-with-autoimmune-neuromuscular-disease/2242677",
    "url_mobile": "https://www.manilatimes.net/2025/12/13/tmt-newswire/globenewswire/fda-approves-amgens-uplizna-inebilizumab-cdon-for-generalized-myasthenia-gravis-gmg-expanding-treatment-options-for-patients-living-with-autoimmune-neuromuscular-disease/2242677/amp",
    "title": "FDA Approves Amgen UPLIZNA\u00ae ( inebilizumab - cdon ) for Generalized Myasthenia Gravis ( gMG ), Expanding Treatment Options for Patients Living with Autoimmune Neuromuscular Disease",
    "seendate": "20251212T183000Z",
    "socialimage": "https://www.manilatimes.net/manilatimes/uploads/images/2025/12/13/865776.png",
    "domain": "manilatimes.net",
    "language": "English",
    "sourcecountry": "Philippines"
  }
}